• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides

Introduction to 4-butoxybenzene-1-sulfonamide (CAS No. 1138-58-5)

4-butoxybenzene-1-sulfonamide, identified by the Chemical Abstracts Service Number (CAS No.) 1138-58-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of sulfonamides, which are widely recognized for their diverse biological activities and therapeutic potential. The structural features of 4-butoxybenzene-1-sulfonamide, comprising a butoxy group attached to a benzene ring sulfonated at the para position, contribute to its unique chemical properties and reactivity, making it a valuable intermediate in synthetic chemistry and drug development.

The butoxybenzene moiety in the molecular structure imparts hydrophobicity, while the sulfonamide group enhances water solubility and bioavailability, which are critical factors in pharmaceutical applications. These characteristics make 4-butoxybenzene-1-sulfonamide a promising candidate for further exploration in medicinal chemistry. Recent studies have highlighted its potential role in the development of novel therapeutic agents, particularly in addressing inflammatory and infectious diseases.

In the realm of academic research, 4-butoxybenzene-1-sulfonamide has been investigated for its interaction with biological targets such as enzymes and receptors. Its sulfonamide moiety is known to exhibit inhibitory effects on various metabolic pathways, which has sparked interest in its possible applications as an anti-inflammatory or antimicrobial agent. For instance, preliminary in vitro studies have demonstrated that derivatives of 4-butoxybenzene-1-sulfonamide can modulate the activity of cyclooxygenase (COX) enzymes, which are key players in the inflammatory response.

Moreover, the pharmaceutical industry has shown interest in leveraging the structural framework of 4-butoxybenzene-1-sulfonamide to design more advanced drug candidates. By incorporating modifications such as halogen substitutions or additional functional groups, researchers aim to enhance the compound's binding affinity and selectivity towards specific biological targets. This approach aligns with the growing trend toward structure-based drug design, where computational modeling and high-throughput screening are employed to identify lead compounds with optimal pharmacokinetic profiles.

The synthesis of 4-butoxybenzene-1-sulfonamide involves multi-step organic reactions, typically starting from commercially available precursors like butylated benzene derivatives. The introduction of the sulfonamide group is achieved through nucleophilic substitution or condensation reactions, depending on the synthetic route employed. Advances in synthetic methodologies have enabled more efficient and scalable production processes, facilitating access to larger quantities of this compound for research purposes.

From a chemical perspective, 4-butoxybenzene-1-sulfonamide exhibits interesting physicochemical properties that make it suitable for various applications beyond pharmaceuticals. Its moderate solubility in both organic and aqueous media allows for versatile formulation strategies, which is advantageous in drug delivery systems. Additionally, its stability under standard conditions ensures compatibility with a wide range of analytical techniques used for characterization and quality control.

The growing body of literature on 4-butoxybenzene-1-sulfonamide underscores its significance as a building block in medicinal chemistry. Researchers continue to explore its potential through interdisciplinary collaborations, combining expertise from organic chemistry, biochemistry, and pharmacology. Such collaborative efforts are essential for translating laboratory findings into tangible therapeutic benefits for patients worldwide.

In conclusion, 4-butoxybenzene-1-sulfonamide (CAS No. 1138-58-5) represents a fascinating compound with broad applicability in pharmaceutical research and industrial chemistry. Its unique structural features and demonstrated biological activities position it as a key player in the development of novel drugs targeting various diseases. As scientific understanding advances and new synthetic techniques emerge, the future prospects for this compound remain promising, offering exciting opportunities for innovation and discovery.

• 1132-19-0(4-ethoxybenzene-1-sulfonamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)